Vanda Pharmaceuticals
VNDA
VNDA
109 hedge funds and large institutions have $571M invested in Vanda Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 32 increasing their positions, 34 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 34
Holders
109
Holding in Top 10
1
Calls
$56.9M
Puts
$13.2M
Top Buyers
| 1 | +$19.8M | |
| 2 | +$16M | |
| 3 | +$14.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$14M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.73M |
Top Sellers
| 1 | -$9.65M | |
| 2 | -$8.96M | |
| 3 | -$8.92M | |
| 4 |
O
OrbiMed
New York
|
-$7.5M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$4.91M |